Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers large-volume therapeutics via subcutaneous administration, with the aim of improving convenience, potentially supporting improved safety outcomes, and advancing healthcare system economics. For more information, please visit www.enableinjections.com. *The enFuse System has received device marketing authorizations from several ex-U.S. regulatory authorities. Combination product approval with a specific drug granted in the U.S. More information: enableinjections.com/approvals
Looking for a particular Enable Injections, Inc. employee's phone or email?
The Enable Injections, Inc. annual revenue was $14.8 million in 2026.
Mike Hooven is the President and CEO of Enable Injections, Inc..
168 people are employed at Enable Injections, Inc..
Enable Injections, Inc. is based in Cincinnati, Ohio.
The NAICS codes for Enable Injections, Inc. are [325, 32, 32541, 3254].
The SIC codes for Enable Injections, Inc. are [28, 283].